Publications

Export 1755 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
Journal Article
Kennedy SH, Lam RW, McIntyre RS, S Tourjman V, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, Macqueen GM et al..  2016.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.. Can J Psychiatry. 61(9):540-60.
Kennedy SH, Lam RW, McIntyre RS, S Tourjman V, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, Macqueen GM et al..  2016.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.. Can J Psychiatry. 61(9):540-60.
Kennedy SH, Lam RW, McIntyre RS, S Tourjman V, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, Macqueen GM et al..  2016.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.. Can J Psychiatry. 61(9):540-60.
Kennedy SH, Lam RW, McIntyre RS, S Tourjman V, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, Macqueen GM et al..  2016.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.. Can J Psychiatry. 61(9):540-60.
Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P et al..  2005.  Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.. Bipolar Disord. 7 Suppl 3:5-69.
Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P et al..  2005.  Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.. Bipolar Disord. 7 Suppl 3:5-69.
Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P et al..  2005.  Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.. Bipolar Disord. 7 Suppl 3:5-69.
Malla A, Iyer SN, Shah JL, Joober R, Boksa P, Lal S, Fuhrer R, Andersson N, Abdel-Baki A, Hutt-MacLeod D et al..  2018.  Canadian response to need for transformation of youth mental health services: ACCESS Open Minds (Esprits ouverts).. Early Interv Psychiatry.
Mbekou V, Gignac M, MacNeil S, Mackay P, Renaud J.  2014.  The CBCL dysregulated profile: an indicator of pediatric bipolar disorder or of psychopathology severity? J Affect Disord. 155:299-302.
Mbekou V, Gignac M, MacNeil S, Mackay P, Renaud J.  2014.  The CBCL dysregulated profile: an indicator of pediatric bipolar disorder or of psychopathology severity? J Affect Disord. 155:299-302.
Mbekou V, Gignac M, MacNeil S, Mackay P, Renaud J.  2014.  The CBCL dysregulated profile: an indicator of pediatric bipolar disorder or of psychopathology severity? J Affect Disord. 155:299-302.
Miron J, Picard C, Nilsson N, Frappier J, Dea D, Théroux L, Poirier J.  2018.  CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease.. Alzheimers Dement.
Heshmati M, Aleyasin H, Ménard C, Christoffel DJ, Flanigan ME, Pfau ML, Hodes GE, Lepack AE, Bicks LK, Takahashi A et al..  2018.  Cell-type-specific role for nucleus accumbens neuroligin-2 in depression and stress susceptibility.. Proc Natl Acad Sci U S A. 115(5):1111-1116.
Heshmati M, Aleyasin H, Ménard C, Christoffel DJ, Flanigan ME, Pfau ML, Hodes GE, Lepack AE, Bicks LK, Takahashi A et al..  2018.  Cell-type-specific role for nucleus accumbens neuroligin-2 in depression and stress susceptibility.. Proc Natl Acad Sci U S A. 115(5):1111-1116.
Devorak J, Torres-Platas SGabriela, Davoli MAntonietta, Prud'homme J, Turecki G, Mechawar N.  2015.  Cellular and Molecular Inflammatory Profile of the Choroid Plexus in Depression and Suicide.. Front Psychiatry. 6:138.
Laidi C, Boisgontier J, M Chakravarty M, Hotier S, d'Albis M-A, Mangin J-FOis, Devenyi GA, Delorme R, Bolognani F, Czech C et al..  2017.  Cerebellar anatomical alterations and attention to eyes in autism.. Sci Rep. 7(1):12008.
Laidi C, Boisgontier J, M Chakravarty M, Hotier S, d'Albis M-A, Mangin J-FOis, Devenyi GA, Delorme R, Bolognani F, Czech C et al..  2017.  Cerebellar anatomical alterations and attention to eyes in autism.. Sci Rep. 7(1):12008.
Romero JE, Coupé P, Giraud R, Ta V-T, Fonov V, Park MTae M, M Chakravarty M, Voineskos AN, Manjón JV.  2017.  CERES: A new cerebellum lobule segmentation method.. Neuroimage. 147:916-924.
Benoit A, Bodnar M, Malla AK, Joober R, Bherer L, Lepage M.  2014.  Changes in memory performance over a 12-month period in relation to achieving symptomatic remission after a first-episode psychosis.. Schizophr Res. 153(1-3):103-8.
Meng X, MJ Fleury, Bamvita JM, Grenier G, Caron J..  2018.  Changes in percentages of perceived met needs for care over time in a Canadian longitudinal cohort.. Psychiatry Res. 269:579-584.
Powell GAntonio, Adair CE, Streiner DL, Mayo N, Latimer E.  2017.  Changes in quality of life from a homelessness intervention: true change, response shift, or random variation.. Qual Life Res. 26(7):1853-1864.
Roostaei T, Sadaghiani S, Park MTae M, Mashhadi R, Nazeri A, Noshad S, Salehi MJavad, Naghibzadeh M, Moghadasi ANaser, Owji M et al..  2016.  Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.. Neurology. 86(5):410-7.
Roostaei T, Sadaghiani S, Park MTae M, Mashhadi R, Nazeri A, Noshad S, Salehi MJavad, Naghibzadeh M, Moghadasi ANaser, Owji M et al..  2016.  Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.. Neurology. 86(5):410-7.
Yoo JHoon, Borsodi A, Tóth G, Benyhe S, Gaspar R, Matifas A, Kieffer BL, Metaxas A, Kitchen I, Bailey A.  2017.  Characterization of [(3)H] oxymorphone binding sites in mouse brain: Quantitative autoradiography in opioid receptor knockout mice.. Neurosci Lett. 643:16-21.
Yoo JHoon, Borsodi A, Tóth G, Benyhe S, Gaspar R, Matifas A, Kieffer BL, Metaxas A, Kitchen I, Bailey A.  2017.  Characterization of [(3)H] oxymorphone binding sites in mouse brain: Quantitative autoradiography in opioid receptor knockout mice.. Neurosci Lett. 643:16-21.

Pages